Browse the evidence

There has been little attention paid to designs, methods, and analytic techniques for early phase trials in behavioral intervention research.

More focus is needed on innovative designs for early phase trials in behavioral interventions.

No significant associations were found between LCD scores and mortality risk in other racial and ethnic groups.

Practitioners should be aware that LCD scores may not be relevant for mortality risk in non-Hispanic populations.

Despite extensive research, many unknowns remain in the field of nutrition due to the difficulty of studying lifestyle factors in isolation.

Practitioners should remain aware of the complexities and uncertainties in nutrition research.

No clear association existed between fiber or vegetable intake and risk of colon cancer.

Practitioners may consider that increasing fiber or vegetable intake may not significantly lower colon cancer risk.

No significant association was observed between dietary patterns and rectal cancer.

Dietary patterns may not influence the risk of rectal cancer in women.

Mitochondrial dysfunction, specifically the loss of mild depolarization in short-lived mice, contributes to aging by increasing ROS-mediated protein damage.

Maintaining mitochondrial health through exercise and healthy metabolism may preserve the 'mild depolarization' state seen in long-lived species, potentially reducing oxidative stress.

Hyperactivation of PARP1 due to persistent DNA damage depletes cellular NAD+, which inhibits SIRT1 activity and leads to mitochondrial dysfunction, thereby accelerating aging and neurodegeneration.

Chronic DNA damage can drain your cells' energy resources (NAD+) by forcing them to constantly repair DNA. This impairs mitochondrial function. Strategies that support NAD+ levels (like exercise or potentially specific supplements, though not explicitly dosed here) might help mitigate this drain, but the primary goal is minimizing DNA damage.

Adipocyte-derived fatty acids, released via lipolysis (ATGL/HSL), are taken up by breast cancer cells and drive proliferation and migration through increased fatty acid oxidation (CPT1A) and electron transport chain activity.

This research suggests that in obesity, fat cells release fatty acids that fuel breast cancer growth. While this is an in vitro finding, it implies that metabolic factors linked to obesity (like high fatty acid availability) may promote cancer progression. It does not currently translate to a specific dietary intervention for patients, but highlights the importance of metabolic health in cancer risk.

Probiotic therapy does not significantly affect body mass index (BMI), blood glucose (GLU), or low-density lipoprotein (LDL) levels in NAFLD patients.

Do not expect probiotics to help you lose weight or lower your LDL cholesterol if you have fatty liver. They may help your liver enzymes and inflammation, but for weight and cholesterol management, you still need to focus on diet and exercise.

Chronic systemic administration of low-dose 2,4-dinitrophenol (DNP) acts as a caloric restriction mimetic by inducing mild mitochondrial uncoupling, which reduces oxidative stress, improves metabolic markers, and significantly extends lifespan in mice.

This research suggests that mild mitochondrial uncoupling can mimic the longevity and metabolic benefits of caloric restriction. In mice, low-dose DNP extended lifespan and improved metabolic health without reducing food intake. However, DNP is toxic at higher doses and is not approved for human use; this paper serves as a proof-of-concept for developing safer uncoupling agents rather than a recommendation for self-experimentation.

Central administration of Brain-Derived Neurotrophic Factor (BDNF) to the paraventricular nucleus (PVN) or ventromedial hypothalamus (VMN) reduces food intake, increases energy expenditure, and reverses diet-induced obesity in rodents.

This research highlights that the brain, specifically the hypothalamus, plays a critical role in regulating body weight through BDNF. While direct injection is not a practical human intervention, the paper notes that exercise increases hippocampal and muscle BDNF. Therefore, engaging in physical activity may naturally support the neurobiological pathways that help regulate appetite and energy expenditure, potentially aiding in weight management and metabolic health.

Loss of the mitochondrial protein BNip3 in the liver causes hepatic steatosis and steatohepatitis by increasing lipid synthesis, reducing fatty acid oxidation, and impairing mitochondrial integrity.

Maintaining healthy mitochondrial turnover (mitophagy) is crucial for liver health. While increasing mitochondrial biogenesis (e.g., through exercise) is generally beneficial, it must be balanced with the clearance of damaged mitochondria. Disruption in this balance can lead to fatty liver disease, even if total mitochondrial numbers appear high.

BNip3 is required for proper hepatic glucose output during fasting; its absence impairs gluconeogenesis and glycogenolysis, leading to hypoglycemia.

Fasting requires a functional liver to maintain blood sugar. If your liver's ability to clear damaged mitochondria (via BNip3) is compromised, you may experience hypoglycemia or difficulty maintaining energy levels during fasting periods.

Genetic deficiency of the enzyme CD38 protects against high-fat diet-induced obesity by enhancing energy expenditure and preventing glucose intolerance.

This research suggests that the enzyme CD38 plays a critical role in how our bodies store fat when eating a high-fat diet. By depleting NAD, CD38 inhibits the SIRT1-PGC1alpha pathway, which is responsible for burning energy and creating mitochondria. Inhibiting CD38 (as seen in knockout mice) prevents obesity even on a high-fat diet. For humans, this highlights the importance of NAD levels and SIRT1 activity (potentially influenced by exercise or compounds like resveratrol) in managing weight, rather than just caloric intake alone.

Increased mitochondrial respiration and biogenesis are prerequisites for the adipogenic differentiation of human mesenchymal stem cells (hMSCs); inhibiting mitochondrial function via hypoxia, rotenone, or TFAM knockdown suppresses this differentiation.

This research highlights that cellular energy metabolism is not just a byproduct but a driver of cell identity. For therapeutic applications involving stem cells (like treating obesity or heart disease), ensuring mitochondrial health and function may be as important as the signaling molecules used to direct cell growth. It suggests that metabolic interventions could potentially influence fat cell formation by targeting mitochondrial efficiency.

Higher body mass index (BMI) is associated with improved overall and disease-specific survival in patients with HNSCC, with obese and overweight patients showing significantly better outcomes than normal-weight patients.

For HNSCC patients, maintaining a higher BMI (overweight or obese range) may be protective against mortality during radiotherapy. This suggests that aggressive nutritional support to prevent weight loss and preserve fat and muscle mass is crucial, as these reserves provide metabolic protection.

During early critical illness, intramuscular lipid delivery (from enteral or parenteral nutrition) is bioenergetically inert and does not contribute to ATP content or muscle mass preservation.

In the first week of critical illness, standard lipid-based nutrition does not appear to fuel muscle energy or prevent muscle loss because the muscle's mitochondria are dysfunctional. This suggests that early lipid delivery may be ineffective for muscle preservation in this specific acute phase.

SIRT3 protects against oxidative stress and hearing loss during aging by deacetylating and activating antioxidant enzymes (SOD2, IDH2) and components of the electron transport chain.

SIRT3 helps protect mitochondria from oxidative damage by activating antioxidant enzymes and the electron transport chain. This protection is crucial for maintaining hearing and overall cellular health during aging.

SIRT3 acts as a tumor suppressor by suppressing the Warburg effect and HIF-1alpha activation, thereby inhibiting tumor growth and progression.

SIRT3 helps prevent cancer by suppressing the Warburg effect, which is the tendency of cancer cells to rely on glycolysis. Maintaining high SIRT3 levels may help keep cells in a healthier metabolic state.

Genetic overexpression of SIRT6 extends median and maximal lifespan in both male and female C57BL/6 mice by preserving hepatic gluconeogenesis and energy homeostasis during aging.

This research identifies SIRT6 as a key regulator of healthy aging in mice, specifically by maintaining the liver's ability to produce glucose (gluconeogenesis) from precursors like lactate and glycerol during fasting. This prevents the metabolic decline and frailty associated with aging. While this is a genetic model, it suggests that supporting metabolic flexibility and hepatic health may be crucial for longevity. For humans, this underscores the importance of maintaining metabolic health through regular physical activity and potentially time-restricted eating patterns that engage gluconeogenic pathways, rather than seeking a simple genetic fix.

Maternal prenatal macronutrient and energy intakes are not strongly associated with offspring fat mass or lean mass at ages 9-11.

While maternal diet during pregnancy may influence a child's future food preferences, it does not appear to directly determine the child's fat or lean mass at age 10. This suggests that postnatal lifestyle and environment play a crucial role in body composition.

Mild depolarization of the inner mitochondrial membrane, mediated by mitochondria-bound hexokinases and creatine kinases, prevents the generation of mitochondrial reactive oxygen species (mROS) and is a crucial component of anti-aging mechanisms in long-lived mammals.

Longevity is linked to the ability of your cells to maintain 'mild depolarization' of mitochondria, a state where energy production is efficient enough to make ATP but low enough to prevent damaging ROS. This state is maintained by specific enzymes (hexokinases) bound to mitochondria. In short-lived animals, this mechanism fails with age, leading to oxidative damage. In long-lived animals, it persists. While you cannot directly 'dose' this mechanism, supporting mitochondrial health through exercise and metabolic flexibility may help preserve these kinase-mediated protective pathways.

Mitochondrial ROS production rates correlate with species-specific aging rates, and targeted mitochondrial catalase expression significantly extends median and maximum lifespan in mice.

Focus on mitochondrial health through exercise and caloric restriction, which naturally reduce ROS production and extend lifespan in models. Do not rely on untargeted antioxidant supplements, as evidence for their efficacy in extending lifespan is lacking or contradictory.

Critically ill patients require significantly higher protein intakes (2.0–2.5 g/kg/day) than standard guidelines (1.2–1.5 g/kg/day) to achieve positive nitrogen balance and potentially improve survival.

For critically ill patients without kidney failure, medical teams should consider protein intakes of 2.0–2.5 g/kg/day. This higher dose is necessary to counteract the severe catabolic state of critical illness and achieve positive nitrogen balance, which may support survival.